Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners selected Luke Forman, a Science-Business major at University of Notre Dame, as its first summer intern. This is the inaugural year for Pharmaceutical Compliance Partners’ internship program, allowing students to learn about drug development, pharmaceutical compliance, and business operations of life sciences firms. - May 25, 2022 - Pharmaceutical Compliance Partners

Molekule Consulting Announces the Launch of E.U. - Based Operations

Molekule Consulting Announces the Launch of E.U. - Based Operations

Molekule Consulting announces the launch of an E.U. - based business / Molekule Hub continuing their focus on the development of global strategy and advisory services for the biopharmaceutical sector. - May 24, 2022 - Molekule Consulting

Tavicare Presents Pioneering COVID-19 Monoclonal Antibody IV Therapy for High-Risk Patients in MD

Tavicare Presents Pioneering COVID-19 Monoclonal Antibody IV Therapy for High-Risk Patients in MD

The state of Maryland Health Department has selected the medical facility to provide the antibody therapy IV to affected patients. - April 06, 2022 - Tavicare Inc

Pipelinepharma Marketplace Records Quadruple Growth Over a Single Year

The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year. As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category. New finished dosage form categories for medical devices and nutraceuticals will also be launched in the coming months. - April 01, 2022 - Pipelinepharma

Tavicare Offers Award-Winning Care for Feminine Health Problems

Tavicare Offers Award-Winning Care for Feminine Health Problems

“The 'big picture' approach isn’t just about looking at disease or dysfunction — it’s about looking at a patient in their entirety,” declares Dr. Tavakoli. - March 07, 2022 - Tavicare Inc

Hormonal Treatments by TaviCare is Enabling People to Live Their Life to the Fullest in Chevy Chase, Maryland

Hormonal Treatments by TaviCare is Enabling People to Live Their Life to the Fullest in Chevy Chase, Maryland

Tavicare, a Maryland based medical facility, is helping people with medical conditions through its wide range of medical treatments - March 07, 2022 - Tavicare Inc

Tavicare’s Advanced GAPS Diet Protocol is Helping Patients Get Remarkable Results in as Little as Six Months

Tavicare’s Advanced GAPS Diet Protocol is Helping Patients Get Remarkable Results in as Little as Six Months

Now patients don’t have to wait for years to cure their chronic or urgent health problems with Tavicare’s carefully tailored GAPS protocol. - March 04, 2022 - Tavicare Inc

Cooperative Buying to Help Launch New Medicines in Small Markets

Large manufacturer minimum order quantities put specialist medicines out of reach of buyers in smaller markets. By grouping pharmaceutical orders from different buyers into a single collective bulk order, Pipelinepharma will help buyers to reach the minimum order quota. The initiative further builds upon Pipelinepharma’s mission to provide better access to medicines for patients all around the world. - February 17, 2022 - Pipelinepharma

Pharmaceutical Companies Shift to Near-Shore Medicines Sourcing as Supply Chain Risks Intensify

With global supply chains under stress due to COVID-19 pandemic, European pharmaceutical companies and distributors are increasingly looking for alternative supply channels inside the EU block. - December 16, 2021 - Pipelinepharma

Pipelinepharma Closes €1.3M Seed Round to Shift Pharmaceutical Dealmaking Online

The European B2B pharmaceutical marketplace closed a venture seed round led by Practica Capital. Iron Wolf Capital, Pandos and a group of angel investors also participated in the funding round. - October 09, 2021 - Pipelinepharma

G1 Care Pharma Selected Authorized Distributer of Vaidyaratnam and Himalaya Products

G1 Care Pharma is a rising hybrid digital pharma retail chain company based in Kota, Rajasthan, India with the aim to provide generic medicines at low costs. G1 Care Pharma is also and authorized distributer of Vaidyaratnam and Himalaya Wellness Ayurvedic products in India. G1 Care Pharma is a... - November 07, 2020 - G1 Care Pharma

3Sixty Pharma Solutions Announces Successful Approval of FDA Investigational New Drug Application

3Sixty Pharma Solutions LLC., www.3sixtypharma.com, has announced the successful submission to FDA, and approval of, an Investigational New Drug (IND) Application on behalf of one of its clinical-stage biotech clients. 3Sixty Pharma Solutions’ 360 Start-Up arm continues to be committed to... - October 15, 2020 - 3Sixty Pharma Solutions

Part B Access for Seniors and Physicians (ASP) Coalition Statement Regarding the Trump Administration’s Recently Announced Executive Order

The Part B Access for Seniors and Physicians (ASP) Coalition released the following statement regarding the Trump Administration’s recently announced Executive Order: “In a letter to lawmakers in 2018, the ASP Coalition warned about the International Pricing Index Model (IPI) and the... - July 24, 2020 - Part B Access for Seniors and Physicians Coalition

Experimentica Ltd. Announces the Successful Acquisition of the Ophthalmic Contract Research Division from Ophthy-DS, Inc.

Experimentica Ltd. Announces the Successful Acquisition of the Ophthalmic Contract Research Division from Ophthy-DS, Inc.

Experimentica Ltd., a leader in preclinical ophthalmic drug discovery services, announces the successful acquisition of the contract research division from Ophthy-DS, Inc., a Michigan-based preclinical contract research organization (CRO) specializing in non-regulated drug discovery services and medical device testing for ophthalmic indications. - May 22, 2020 - Experimentica Ltd

Announcing Vegan Skincare Products from Moongate Botanicals

Sharon Yancey founded Moongate Botanicals in Austin, Texas after struggling to find products that matched her lifestyle. Moongate Botanicals skincare products are vegan, cruelty-free, and eco-friendly. These products do not contain petroleum-based ingredients, harmful chemicals, and synthetic fragrances. - March 03, 2020 - Moongate Botanicals

3Sixty Pharma Solutions Partners with Westchester Biotech Project

3Sixty Pharma Solutions Partners with Westchester Biotech Project

Leveraging its “360Start-Up” Powerhouse to Grow a Dynamic Non-Profit for Scientists - January 11, 2020 - 3Sixty Pharma Solutions

3Sixty Pharma Solutions Announces Successful Submission of Start-Up Biotech Investigational New Drug Application

3Sixty Pharma Solutions LLC, www.3sixtypharma.com, last week announced the successful submission to FDA of its first Investigational New Drug (IND) Application on behalf of one of its start-up biotech clients. This news comes on the heels of the formal organization in 2018 of 3Sixty Pharma... - December 16, 2019 - 3Sixty Pharma Solutions

Pharmacy Town Host Grand Opening Event

Pharmacy Town hosted its grand opening event on June 28th, 2019. The newest pharmacy in town is located at 1560 State Highway 35 Ocean, NJ inside the Super Foodtown of Ocean. Special guests at the Grand Opening were Mayor Christopher Siciliano, Deputy Mayor Richard Long, Assemblyman Eric... - July 09, 2019 - Pharmacy Town

Pharmacy Town Set to Deliver Unmet Healthcare Needs to Patients in Ocean, NJ

“With healthcare being so complex these days, Pharmacy Town’s main goal is to deliver quality healthcare in a caring, compassionate, and cost-effective manner. Patients come first at Pharmacy Town!” said Dev Tailor, pharmacist. - June 07, 2019 - Pharmacy Town

New Xcenda White Paper Discusses Why the International Pricing Index Model is Not the Answer to Reforming Medicare Part B

White Paper Highlights Impact of IPI Model on Patients and Health Care Providers - May 09, 2019 - Part B Access for Seniors and Physicians Coalition

Are Antioxidants the Solution to Burning and Itchy Eyes?

A recently published study in The Ocular Surface journal authored by Experimentica Ltd. in collaboration with researchers from Loyola University Chicago and the University of Missouri – Kansas City suggests that a topical antioxidant formulation can improve the pathological signs associated with dry-eye disease. - March 26, 2019 - Experimentica Ltd

Patient & Provider Groups Oppose Legislation to Enable International Reference Pricing for Seniors’ Drugs

Coalition believes proposal by Sen. Sanders, Reps. Khanna and Cummings is likely to restrict access to lifesaving medicines and lead to adverse unintended consequences. - January 11, 2019 - Part B Access for Seniors and Physicians Coalition

339 Groups Urge Congress to Halt International Pricing Index Model

Part B Access for Seniors and Physicians Coalition-organized letter highlights model’s threats to patient choice and American healthcare innovation. - December 18, 2018 - Part B Access for Seniors and Physicians Coalition

New Report: ASP Rates Do Not Encourage Doctors to Prescribe High-Cost Drugs.

Coalition stresses findings of new report as policymakers consider potentially harmful changes to the Medicare Part B program - December 18, 2018 - Part B Access for Seniors and Physicians Coalition

Vibcare Pharma Pvt. Ltd. Producing and Marketing Affordable Generic Pharmaceutical Drugs

Vibcare Pharma Pvt. Ltd. Producing and Marketing Affordable Generic Pharmaceutical Drugs

Vibcare Pharma, a leading PCD pharma company operating in India and a provider of PCD pharma franchise, is offering cost-effective generic drugs in domestic, as well as international markets. - September 18, 2018 - Vibcare Pharma

Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland - XXIII Biennial Meeting of the International Society for Eye Research September 9-13, 2018 | Belfast

The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd

Experimentica Ltd. Amongst the Most Promising Finnish Young Innovative Companies

Experimentica Ltd. Amongst the Most Promising Finnish Young Innovative Companies

Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12... - February 21, 2018 - Experimentica Ltd

Blue Diesel Data Science Introduces Pharmaceutical Insight Platform Reducing Research Time from Weeks to Minutes

Blue Diesel Data Science Introduces Pharmaceutical Insight Platform Reducing Research Time from Weeks to Minutes

Blue Diesel Data Science announces the beta launch of its pharmaceutical platform VisionaryRX. VisionaryRX provides a deep and comprehensive view into the drug industry. It relates multiple forms of industry standard data in the pharmaceutical industry under one view. Because VisionaryRX uses over 50 million rows of information, the result is fast and complete visibility into the industry. Useful for pharmaceutical manufacturing, labeling, partnerships and strategic direction insight. - December 10, 2017 - Blue Diesel Data Science

Tanner Pharma Group to Attend Upcoming CPHI Worldwide Conference

Top executives from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend the CPhI Worldwide event on October 24 – 26 in Messe Frankfurt, Germany. Tanner Pharma leverages more than 15 years of pharma services experience to... - October 21, 2017 - Tanner Pharma Group

G&L Scientific Announces the Appointment of Richard Edmunds as Vice President, Regulatory Affairs

G&L Scientific Announces the Appointment of Richard Edmunds as Vice President, Regulatory Affairs

Global provider of Clinical & Regulatory Affairs consultancy services continues to attract top talent. - October 09, 2017 - G&L Scientific Inc

Pharmaceutical Company CJSC "ARAY" Announces Construction of Pharmaceutical Plant with Two Hormonal Drugs Research, Development and Production in Bishkek, Kyrgyzstan

Pharmaceutical company CJSC ARAY announced today that it is in active research and development phase of a new Hormone Replacement Therapy (HRT) drug, called SUSTADREN (TM), housed in Bishkek, Kyrgyz Republic. - August 19, 2017 - CJSC ARAY

Refine Technology, LLC Establishes East Coast Distribution for New 1.5” Single Use Connector

Refine Technology, LLC is best known for the award winning ATF™ system for cell perfusion. It is now reinventing itself with new products for cell biology and bioprocesing applications, beginning with a new 1.5" Single Use Connector to address the challenges of rapid sterile fluid transfer in large volume single use bioprocessing. - July 13, 2017 - Refine Technology, LLC

G&l Scientific Inc. Announces Its Expansion Into Regulatory Affairs, Complementing Its Industry-Leading Clinical Research Offering

G&l Scientific Inc. Announces Its Expansion Into Regulatory Affairs, Complementing Its Industry-Leading Clinical Research Offering

G&L Scientific Inc, a company founded by Peter Griffin and Stephen Loughrey, who together built Pharmalink Consulting into the leading, independent Regulatory Affairs specialist, today announced their intention to once more provide Regulatory Affairs services to life-science clients. G&L... - June 02, 2017 - G&L Scientific Inc

Precision LTC Pharmacy: Servicing Long Term Care Organizations Throughout the Greater New York City Area

Precision LTC Pharmacy: Servicing Long Term Care Organizations Throughout the Greater New York City Area

Precision has experienced significant growth and currently serves thousands of residents in Long Term Care communities. - April 20, 2017 - Precision LTC Pharmacy

G&L Scientific Inc. Announces Opening of New Offices in Cambridge, Massachusetts

G&L Scientific Inc. Announces Opening of New Offices in Cambridge, Massachusetts

G&L Scientific Inc, the leading provider of clinical and scientific consulting and resource to the healthcare industry (http://www.gandlscientific.com), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving access to its expanding team of clinical and scientific consultants and contractors. This is the latest step in G&L’s expansion of its global clinical consulting services throughout the United States. - January 19, 2017 - G&L Scientific Inc

Experimentica Ltd. Appoints New Director of In Vivo Pharmacology

Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately. Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental... - October 22, 2016 - Experimentica Ltd

SHAPE Congratulates Dr. MacRae and Team for Winning the $75 Million "One Brave Idea" Award to End Coronary Heart Disease

SHAPE Congratulates Dr. MacRae and Team for Winning the $75 Million "One Brave Idea" Award to End Coronary Heart Disease

SHAPE congratulates Dr. Calum MacRae and his team at Brigham and Women's Hospital in Boston for winning “One Brave Idea” competition held by American Heart Association, Google’s Life Science (Verily) and Astra-Zeneca. The winner is funded $75 Million for one brave idea that could lead to the development of a cure for coronary heart disease. - October 06, 2016 - SHAPE (Society for Heart Attack Prevention and Eradication)

Tabula Rasa HealthCare to Present Medication Therapy Management Innovations at MTM Summit September 15-16, 2016

Tabula Rasa HealthCare to Present Medication Therapy Management Innovations at MTM Summit September 15-16, 2016

Tabula Rasa HealthCare's (TRHC) Medication Risk Mitigation Matrix(R) brings to Enhanced Medication Therapy Management (EMTM) the ability to identify those Medicare beneficiaries at the highest risk of an adverse drug event and mitigates that risk through personalized interventions. - September 07, 2016 - Tabula Rasa HealthCare

KinderPharm to Celebrate Grand Opening of New Exton Office

Pennsylvania Elected Officials to Participate in Ribbon-Cutting Ceremony and Grand Opening Event; KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking. - August 16, 2016 - KinderPharm LLC

Tabula Rasa HealthCare's Jack Russell Software Innovation Center Kick Off First JRS Coding School Boot Camp September 19

Tabula Rasa HealthCare's Jack Russell Software Innovation Center Kick Off First JRS Coding School Boot Camp September 19

The Jack Russell Software Innovation Center (JRS IC) announced today its first Coding School Boot Camp will be held September 19, - December 6, 2016. Applications must be submitted between August 1 – September 1, 2016. The JRS IC was launched this year by TRHC to develop technology that will solve real health care problems while providing leading-edge value to software innovation. In celebration, a 50% discount off of the tuition is being offered to students. - August 05, 2016 - Tabula Rasa HealthCare

Tabula Rasa HealthCare Launches Jack Russell Software Innovation Center; Tom Wilson Named Executive VP/Chief Technology Innovation Officer

Tabula Rasa HealthCare Launches Jack Russell Software Innovation Center; Tom Wilson Named Executive VP/Chief Technology Innovation Officer

The new JRS IC will provide technology leadership, creativity and training to TRHC and its subsidiaries, as well as the healthcare community at large. Programs and events are designed to engage and collaborate with highly trained professionals in fields of software development, while creating a culture that continuously innovates and focuses on patient safety. - August 05, 2016 - Tabula Rasa HealthCare

Saffa Compounding Pharmacy/Sunshine Care Partners Tulsa. Saffa Pharmacy Announced as Sunshine Care Partners Territory License Owner for Tulsa County, OK.

Saffa Compounding Pharmacy/Sunshine Care Partners Tulsa. Saffa Pharmacy Announced as Sunshine Care Partners Territory License Owner for Tulsa County, OK.

Saffa Compounding Pharmacy is proud to announce its purchase of the Sunshine Care Partners, Tulsa County Territory, and welcomes territory owners Debra Wells DPh, and Karla Taylor, both residents of Tulsa County. Tulsa County physicians serving Chronic Care Patients can partner with Saffa/Sunshine who, after serving the community for over 42 years, is expanding their services to both physicians and patients. - July 07, 2016 - Saffa Compounding Pharmacy

Tabula Rasa HealthCare Subsidiary Medliance Promotes Rebstock to Executive Director

Tabula Rasa HealthCare Subsidiary Medliance Promotes Rebstock to Executive Director

TRHC Chairman and CEO Calvin H. Knowlton named Candy Rebstock Executive Director of its wholly-owned subsidiary, Medliance, which is the leading pharmacy cost management solution for post-acute care. Clients rely on Medliance's adjudication and consulting services to create transparency and increase communication between client skilled nursing facilities and their pharmacy partners. - June 20, 2016 - Tabula Rasa HealthCare

ValueTrak 8.0 Release Re-Imagines Fee-for-Service Scorecarding with New Data Quality Metrics and Robust Customization Capabilities

ValueCentric, the industry leader in healthcare channel intelligence, announced enhancements to their Scorecard capabilities as part of ValueTrak 8.0 software release. Improvements include advanced Specialty and Channel Data Management metrics, integrating data completeness, timeliness, and... - June 15, 2016 - ValueCentric

Tabula Rasa HealthCare CEO Calvin H. Knowlton Named Technology CEO of the Year

Tabula Rasa HealthCare CEO Calvin H. Knowlton Named Technology CEO of the Year

Tabula Rasa HealthCare Chairman and CEO, Calvin H. Knowlton, received the 2016 PACT Enterprise Award for Technology CEO of the Year at a gala event in Philadelphia, May 12. While accepting the award, Knowlton stated, "TRHC results include enhanced medication-related outcomes and greater operational efficiency. The work we are doing in medication informatics, personalized medication management, and compliance/assurance is exciting and, we believe, game changing." - June 03, 2016 - Tabula Rasa HealthCare

ValueCentric’s Training Conference, Focus 2016, Sells-Out in Record Time

ValueCentric, the leader in healthcare channel intelligence, today announced their annual user-training conference, being held in Princeton, NJ May 24th and 25th, has sold out. Anticipation for this event has accelerated with the company’s expanded data service offerings, a significant... - May 20, 2016 - ValueCentric

NJHA Brings Medication Risk Mitigation Services to New Jersey Hospitals Through Strategic Alliance with Tabula Rasa HealthCare

New Jersey Hospital Association and Tabula Rasa HealthCare (TRHC) have entered into a 3-year agreement to offer TRHC's proprietary Medication Risk Mitigation™ products and services to NJHA’s nearly 400 member healthcare organizations. - May 02, 2016 - Tabula Rasa HealthCare

Tabula Rasa HealthCare Names Kristen Propp Creative Director; Healthcare Technology Company Expands Marketing Heft with New Hire

Tabula Rasa HealthCare Names Kristen Propp Creative Director; Healthcare Technology Company Expands Marketing Heft with New Hire

Tabula Rasa HealthCare, Inc. (TRHC) President Orsula V. Knowlton announced graphic designer, Kristen Propp, has joined the healthcare technology company as Creative Director. TRHC is a leader in providing patient-specific, data-driven technology and solutions for health care organizations. - May 02, 2016 - Tabula Rasa HealthCare

ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers

ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric

ValueCentric Expands Specialty Data Quality and Performance Measurement Reporting Capabilities

Dashboards and reports are now available to Specialty manufacturer clients through the ValueTrak Platform. - April 07, 2016 - ValueCentric

Press Releases 1 - 50 of 172